Scientists have identified a gene regulator that may help explain why skeletal muscles gradually lose their ability to maintain strength and clear cellular damage with age.
The gene is called DEAF1. Researchers found that its activity rises in aging muscle, pushing an important growth pathway called mTORC1 into a persistently overactive state. Exercise reduced DEAF1 activity in animal models, restored a healthier balance in mTORC1 signaling and improved muscle function.
The findings were published in the Proceedings of the National Academy of Sciences. The study was conducted by researchers from Duke-NUS Medical School, Singapore General Hospital and Cardiff University using fruit flies and older mice. It did not test a DEAF1-targeting treatment in humans.
The result provides a detailed molecular explanation for one of exercise’s best-known benefits. Physical activity does not simply make muscle fibers larger. It can also influence the genetic controls governing protein production, cellular cleaning and tissue repair.
DEAF1 Is a Gene Regulator, Not an “Aging Gene”
Descriptions of DEAF1 as the gene at the center of muscular aging are useful for attracting attention, but the biology is more complicated.
DEAF1 encodes a transcription factor, a protein that helps control the activity of other genes. The researchers identified it as an important upstream regulator of muscle deterioration, not as the single genetic cause of aging.
Aging affects muscles through numerous interacting processes, including altered nerve signaling, inflammation, mitochondrial changes, reduced stem-cell activity, hormonal shifts and changes in protein metabolism. DEAF1 appears to occupy an influential position within one part of this larger system.
The study found that increased DEAF1 expression raised transcription of the mTOR gene, contributing to excessive activity in mechanistic target of rapamycin complex 1, or mTORC1. This disrupted proteostasis—the cellular balance between producing proteins, maintaining them and removing damaged material.
Exercise did not remove DEAF1 from the animals’ DNA. It reduced the gene’s expression, meaning the cells produced less of its regulatory protein.
mTORC1 Helps Build Muscle but Can Become Too Active
mTORC1 is normally essential to muscle health. It responds to nutrients, mechanical loading and growth signals, helping cells produce proteins and maintain tissue.
That makes the study’s finding appear paradoxical. A pathway associated with muscle growth might be expected to protect older muscles rather than damage them.
The problem is not simply whether mTORC1 is active. Timing and balance matter. Temporary activation following exercise can support adaptation and protein synthesis. Chronic overactivation during aging may favor constant production while interfering with the removal and recycling of worn-out cellular components.
The Duke-NUS researchers found that aging muscles accumulated higher DEAF1 levels, which drove mTORC1 activity upward. Damaged proteins then built up inside muscle cells, creating stress and contributing to weakness. The university’s research summary describes the process as an imbalance between building new proteins and clearing old or defective ones.
Healthy muscle therefore requires more than continual growth. It also needs an effective maintenance system.
Exercise Reactivated the Muscle’s Control System
DEAF1 is normally restrained by a family of regulatory proteins called FOXOs. These proteins influence stress resistance, metabolism, protein breakdown and cellular maintenance.
As muscle ages, FOXO activity can decline. The study suggests that this loss of control allows DEAF1 to rise, mTORC1 to remain overactive and protein quality control to deteriorate.
Exercise changed that relationship. In older mice, endurance exercise activated FOXO signaling, suppressed DEAF1 and reduced excessive mTORC1 activity. The result was improved protein balance and healthier muscle characteristics.
The researchers described a FOXO–DEAF1–mTORC1 axis: FOXO controls DEAF1, DEAF1 regulates mTOR expression, and mTOR affects the balance between muscle growth and cellular cleanup. Experiments in which FOXO was inhibited or DEAF1 was deliberately increased blocked some of exercise’s benefits, supporting the conclusion that this pathway was functionally important rather than merely associated with better muscle health.
This helps explain why exercise can benefit aging muscle even when it does not produce dramatic visible growth. The muscle may be improving its internal maintenance processes.
Autophagy Is a Critical Part of the Effect
One of the processes affected by DEAF1 is autophagy, the system cells use to break down and recycle damaged proteins and structures.
Autophagy is sometimes described as cellular housekeeping. Muscle cells rely on it to remove dysfunctional components that might otherwise accumulate and interfere with contraction, energy production and repair.
A related scientific analysis described DEAF1 as a transcriptional brake on muscle autophagy. Elevated DEAF1 increased mTORC1 signaling and suppressed genes involved in cellular recycling. Exercise lowered DEAF1, restored autophagy-related gene expression and improved the movement of damaged material through the recycling process. The full analysis is available through the open-access article “DEAF1—a transcriptional brake on muscle autophagy”.
This distinction matters because continually stimulating protein production without removing defective proteins would be similar to adding new components to a machine without replacing its damaged parts.
Fruit Flies and Older Mice Showed Similar Results
The researchers tested DEAF1 in more than one animal model to determine whether its effects were limited to a single species.
Increasing DEAF1 in aging fruit flies produced muscle atrophy and poorer climbing performance. Reducing DEAF1 or lowering the downstream TOR pathway improved those defects.
Experiments in older mice produced a similar pattern. Higher DEAF1 activity was associated with excessive mTORC1 signaling and declining muscle quality, while exercise reduced DEAF1 and restored a healthier molecular balance.
The consistency between flies and mice suggests that the pathway has been preserved across evolution. However, that does not guarantee that the intervention will produce identical results in humans. Human muscle aging is influenced by health conditions, medications, diet, activity history and genetic variation that cannot be fully recreated in laboratory animals.
The study should therefore be understood as strong mechanistic evidence rather than proof of a new clinical treatment.
Previous Research Also Linked DEAF1 to Muscle Repair
The same research group had previously investigated DEAF1 in muscle stem cells, which help repair tissue following injury.
That work found that FOXO-regulated DEAF1 contributed to declining autophagy and impaired muscle regeneration with age. Reducing DEAF1 through experimental genetic approaches improved muscle function in older mice. The researchers also reported benefits in animal models of cancer-related muscle wasting.
The open-access study, “FOXO-regulated DEAF1 controls muscle regeneration through autophagy”, showed that intravenous delivery of a gene-silencing treatment lowered DEAF1 in older mice and improved measures of muscle strength and function.
Together, the studies suggest that DEAF1 may influence both mature muscle fibers and the stem cells involved in regeneration.
Exercise May Not Fully Correct Advanced Muscle Decline
The new findings also reveal a possible limit to exercise’s effect.
When DEAF1 remained artificially high or FOXO activity was severely reduced, exercise could not completely restore normal muscle maintenance. This may help explain why the same training program produces stronger benefits in some older individuals than in others.
It does not mean that exercise becomes useless in advanced age. Physical activity can influence cardiovascular health, balance, metabolism and neurological function through many pathways beyond DEAF1. The result instead suggests that severely disrupted muscle biology may require additional support.
Researchers believe that future treatments could potentially suppress DEAF1 or strengthen FOXO activity, reproducing part of exercise’s molecular effect for people who are immobilized, recovering from surgery or living with muscle-wasting conditions. No approved anti-aging therapy currently targets this pathway, and directly manipulating mTORC1 could produce unintended effects because the pathway performs essential functions throughout the body.
The Finding Does Not Turn Exercise Into a Genetic Cure
The phrase “exercise defeats the gene” simplifies what the researchers actually observed.
Exercise changed gene regulation in older animals. It activated FOXO proteins, lowered DEAF1 expression and brought mTORC1 closer to a healthier range. It did not alter the underlying DNA sequence, permanently switch off aging or restore every aspect of youthful muscle.
The importance of the study is more practical. It reveals that age-related muscle decline is not driven only by unavoidable structural wear. At least part of the process is maintained by molecular signals that remain responsive to physical activity.
That responsiveness creates two opportunities. It strengthens the biological case for remaining active throughout life, and it gives researchers a defined pathway that could be investigated for future therapies.
DEAF1 is unlikely to be the final answer to muscular aging. However, it may be an important switch connecting exercise, protein recycling and muscle strength. By showing how physical activity turns that switch down, the study moves science closer to understanding why exercised muscles often age more successfully than inactive ones.
